Elective Urological Surgery Following Coronary Stent Implantation: To Whom, How To Do It?

Area of Science:

• Cardiology
• Urology
• Geriatrics

Background:

• Coronary artery disease (CAD) is a leading cause of mortality, with atherosclerosis increasing in the elderly.
• Stent placement for CAD is common, with ~2 million US procedures annually, leading to a growing patient population.
• Managing patients with coronary artery stents undergoing elective urological surgery presents unique challenges.

Purpose of the Study:

• To review and assess optimal antiplatelet therapy strategies for patients with coronary artery stents undergoing elective urological surgery.
• To determine the appropriate balance of antiplatelet agent dosage and duration to minimize morbidity and mortality.

Main Methods:

• Literature review of studies on coronary artery disease, stent placement, and antiplatelet therapy.
• Analysis of guidelines and clinical evidence regarding perioperative management of patients with stents.
• Assessment of risk factors and outcomes in patients undergoing elective urological procedures.

Main Results:

• Increased life expectancy contributes to a higher prevalence of coronary artery disease and stent use in the elderly.
• Balancing the need for antiplatelet therapy to prevent stent thrombosis against bleeding risks during surgery is critical.
• Evidence-based recommendations for managing antiplatelet therapy in this specific patient cohort are synthesized.

Conclusions:

• Elective urological surgery in patients with coronary artery stents necessitates careful perioperative management.
• Individualized treatment plans considering stent type, time since implantation, and patient comorbidities are essential.
• Optimizing antiplatelet therapy is key to reducing complications and ensuring favorable outcomes.